This CME series provides primary care professionals with the knowledge and skill sets needed to effectively provide standard-of-care medicine within the constraints of a busy office setting. Faculty therapeutic area experts address how to overcome barriers preventing optimal patient outcomes by improving guideline adherence, and optimizing practice performance in areas where guidelines are needed.
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
TRANSFORM Trial: Overview and Potential Implications
TRANSFORM Trial: Overview and Potential Implications
Staging Coronary Risk: A New TRANSFORMative Approach
Staging Coronary Risk: A New TRANSFORMative Approach
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
MACE and SGLT2 Inhibitors: Do They Have an Impact?
MACE and SGLT2 Inhibitors: Do They Have an Impact?
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
ATTR-CM Management: Pearls From Recent Clinical Trials and Tailoring Therapy
ATTR-CM Management: Pearls From Recent Clinical Trials and Tailoring Therapy
ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results